Galapagos is planning to wind down its cell therapy business, completing a whiplash change that saw the biotech go from focusing on the modality to ditching it in six months. Belgium-based Galapagos ...
Shares in Galapagos NV dropped sharply after the Belgian biotech firm said it would wind down its cell-therapy operations, putting paid to plans to sell the business off after no viable offers were ...
Galapagos (NASDAQ:GLPG) ADRs dropped ~13% in the premarket on Tuesday after the Belgian biotech announced plans to wind down its cell therapy business, impacting roughly 365 employees in Europe, the U ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback